Atıf İçin Kopyala
ERDEMOĞLU E., GÜNEY M., Giray S. G., Take G., Mungan T.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.145, sa.2, ss.195-199, 2009 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
145
Sayı:
2
-
Basım Tarihi:
2009
-
Doi Numarası:
10.1016/j.ejogrb.2009.04.034
-
Dergi Adı:
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.195-199
-
Anahtar Kelimeler:
Metformin, Endometrial hyperplasia, Mammalian target of rapamycin, S6K1, Tamoxifen, Estradiol, POLYCYSTIC-OVARY-SYNDROME, MTOR INHIBITOR RAD001, CANCER-CELLS, BREAST-CANCER, GROWTH, PHARMACOKINETICS, APOPTOSIS, HEALTH, RATS
-
Gazi Üniversitesi Adresli:
Evet
Özet
Objective: The effects of metformin on S6K1, which is a crucial effector of mTOR signaling, and on endometrium were studied in a mouse model of endometrial hyperplasia induced by unopposed estradiol or tamoxifen.